Physician profile
Ron Y Mark
NPI 1013917301
$173,327.40
in general payments reported to CMS, 2019-2025
6 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $24K · 2021: $25K · 2022: $26K · 2023: $25K · 2024: $24K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $72K · Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $72,000.00 |
| Food and Beverage | $1,456.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $168,090.04 | 2019-2025 | Venacure 1470 Pro |
| Merz North America, INC. | $2,734.48 | 2020-2023 | Xeomin |
| Boston Scientific Corporation | $1,897.06 | 2019-2023 | Varithena Administration Pack |
| Tactile Systems Technology INC | $539.61 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Biocompatibles, INC. | $36.68 | 2019 | |
| Allergan, INC. | $29.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Mark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.